-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $63

Benzinga·11/04/2026 14:28:19
Listen to the news
Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $60 to $63.